Business Context and Reporting Period
This Form 8-K filing by Zimmer Holdings, Inc. (now Zimmer Biomet Holdings, Inc.) reports corporate governance changes effective December 12, 2013. The report was filed on December 18, 2013.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on board composition and does not contain financial performance data.
Material Changes
- Board Expansion: The Board of Directors increased its size from nine to ten members.
- New Director Election: Paul M. Bisaro was elected to fill the new vacancy effective December 12, 2013.
- Committee Appointments: Mr. Bisaro was appointed to the Compensation and Management Development Committee and the Corporate Governance Committee.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of risks and contingencies. Regarding compensation, Mr. Bisaro will participate in standard non-employee director arrangements and is expected to execute the company's standard indemnification agreement. No material interest in transactions requiring disclosure under Item 404(a) of Regulation S-K was identified.
Investor Verification Checklist
- Verify the full text of the press release (Exhibit 99.1) for additional context on Mr. Bisaro's background.
- Review the definitive proxy statement filed on March 25, 2013, for details on non-employee director compensation.
- Confirm the term expiration date for Mr. Bisaro at the 2014 annual meeting of stockholders.